[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fPKoKSII6KD9jPB-5e8oYE89dlzq7wcfa04JC7Gs98GM":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":7,"truncated":8,"activeTrials":9,"phase3Count":10,"totalEnrollment":11,"activePrograms":12,"nonDrugCount":13,"topConditions":14,"upcomingReadouts":35,"phaseBuckets":36,"rows":43},"University of Lahore",[4,6],"University of Lahore Hospital (ULH)",183,false,36,1,13791,0,171,[15,18,21,24,27,29,31,33],{"name":16,"count":17},"Stroke",21,{"name":19,"count":20},"Neck Pain",6,{"name":22,"count":23},"Adhesive Capsulitis",5,{"name":25,"count":26},"Cerebral Palsy",4,{"name":28,"count":26},"Parkinson Disease",{"name":30,"count":26},"Hemiplegia",{"name":32,"count":26},"Lipid Profile",{"name":34,"count":26},"Cervical Radiculopathy",[],[37,38,39,40,41,42],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[44,72,90,117,135,161,201,227,257,275,303,321,339,365,390,416,434],{"intervention":45,"totalTrials":10,"cells":46},"Sitagliptin + Metformin",{"EARLY_PHASE1":47,"PHASE1":49,"PHASE2":51,"PHASE3":53,"PHASE4":68,"NA":70},{"trials":48,"activeCount":12},[],{"trials":50,"activeCount":12},[],{"trials":52,"activeCount":12},[],{"trials":54,"activeCount":12},[55],{"nctId":56,"briefTitle":57,"status":58,"phases":59,"primaryCompletion":60,"completion":61,"start":62,"enrollment":63,"conditions":64,"interventions":66},"NCT06952231","Effect of Sitagliptin and Empagliflozin in Combination With Metformin on Hs-CRP Levels in Patients With Type 2 Diabetes Mellitus","COMPLETED",[40],"2024-12-10","2025-01-05","2024-05-21",50,[65],"Diabetes Mellitus",[45,67],"Empagliflozin + Metformin",{"trials":69,"activeCount":12},[],{"trials":71,"activeCount":12},[],{"intervention":67,"totalTrials":10,"cells":73},{"EARLY_PHASE1":74,"PHASE1":76,"PHASE2":78,"PHASE3":80,"PHASE4":86,"NA":88},{"trials":75,"activeCount":12},[],{"trials":77,"activeCount":12},[],{"trials":79,"activeCount":12},[],{"trials":81,"activeCount":12},[82],{"nctId":56,"briefTitle":57,"status":58,"phases":83,"primaryCompletion":60,"completion":61,"start":62,"enrollment":63,"conditions":84,"interventions":85},[40],[65],[45,67],{"trials":87,"activeCount":12},[],{"trials":89,"activeCount":12},[],{"intervention":91,"totalTrials":10,"cells":92},"Group 1",{"EARLY_PHASE1":93,"PHASE1":95,"PHASE2":97,"PHASE3":111,"PHASE4":113,"NA":115},{"trials":94,"activeCount":12},[],{"trials":96,"activeCount":12},[],{"trials":98,"activeCount":12},[99],{"nctId":100,"briefTitle":101,"status":58,"phases":102,"primaryCompletion":103,"completion":104,"start":105,"enrollment":106,"conditions":107,"interventions":109},"NCT06439251","Effects of Mulligan Technique With or Without Diclofenac Phonophoresis on Patellofemoral Pain Syndrome.",[38,39],"2025-06-15","2025-07-20","2023-10-18",68,[108],"Patellofemoral Pain Syndrome",[91,110],"Group 2",{"trials":112,"activeCount":12},[],{"trials":114,"activeCount":12},[],{"trials":116,"activeCount":12},[],{"intervention":110,"totalTrials":10,"cells":118},{"EARLY_PHASE1":119,"PHASE1":121,"PHASE2":123,"PHASE3":129,"PHASE4":131,"NA":133},{"trials":120,"activeCount":12},[],{"trials":122,"activeCount":12},[],{"trials":124,"activeCount":12},[125],{"nctId":100,"briefTitle":101,"status":58,"phases":126,"primaryCompletion":103,"completion":104,"start":105,"enrollment":106,"conditions":127,"interventions":128},[38,39],[108],[91,110],{"trials":130,"activeCount":12},[],{"trials":132,"activeCount":12},[],{"trials":134,"activeCount":12},[],{"intervention":136,"totalTrials":10,"cells":137},"20% benzocaine Gel",{"EARLY_PHASE1":138,"PHASE1":151,"PHASE2":153,"PHASE3":155,"PHASE4":157,"NA":159},{"trials":139,"activeCount":12},[140],{"nctId":141,"briefTitle":142,"status":58,"phases":143,"primaryCompletion":144,"completion":145,"start":146,"enrollment":147,"conditions":148,"interventions":150},"NCT06804616","Pain Reduction Using Vibration and Topical Anesthesia",[37],"2024-12-30","2025-02-03","2024-11-28",60,[149],"Pain Management",[136],{"trials":152,"activeCount":12},[],{"trials":154,"activeCount":12},[],{"trials":156,"activeCount":12},[],{"trials":158,"activeCount":12},[],{"trials":160,"activeCount":12},[],{"intervention":162,"totalTrials":163,"cells":164},"Constraint-Induced Movement Therapy",2,{"EARLY_PHASE1":165,"PHASE1":167,"PHASE2":169,"PHASE3":171,"PHASE4":173,"NA":175},{"trials":166,"activeCount":12},[],{"trials":168,"activeCount":12},[],{"trials":170,"activeCount":12},[],{"trials":172,"activeCount":12},[],{"trials":174,"activeCount":12},[],{"trials":176,"activeCount":12},[177,190],{"nctId":178,"briefTitle":179,"status":58,"phases":180,"primaryCompletion":181,"completion":182,"start":183,"enrollment":184,"conditions":185,"interventions":189},"NCT06807814","COMPERATIVE EFFECTS of CONSTRAINT- INDUCED MOVEMENT THERAPY and MIRROR THERAPY on FUNCTIONAL AMBULATION and QUALITY of LIFE in CHRONIC STROKE PATIENTS",[42],"2024-11-12","2024-12-20","2024-01-26",56,[16,186,187,188],"Stroke Rehabilitation","Mirror Therapy","Quality of Life (QOL)",[162],{"nctId":191,"briefTitle":192,"status":58,"phases":193,"primaryCompletion":194,"completion":195,"start":196,"enrollment":106,"conditions":197,"interventions":200},"NCT06910904","CONSTRAINT-INDUCED MOVEMENT THERAPY (CIMT) VS. MIRROR THERAPY (MT) ON HAND FUNCTION AND SPASTICITY IN PATIENTS WITH HEMIPARESIS",[42],"2025-03-19","2025-03-28","2024-09-15",[16,198,199],"Hemiparesis","Hemiparesis After Stroke",[162,187],{"intervention":202,"totalTrials":10,"cells":203},"Vitamin C",{"EARLY_PHASE1":204,"PHASE1":206,"PHASE2":208,"PHASE3":210,"PHASE4":212,"NA":214},{"trials":205,"activeCount":12},[],{"trials":207,"activeCount":12},[],{"trials":209,"activeCount":12},[],{"trials":211,"activeCount":12},[],{"trials":213,"activeCount":12},[],{"trials":215,"activeCount":12},[216],{"nctId":217,"briefTitle":218,"status":58,"phases":219,"primaryCompletion":220,"completion":221,"start":222,"enrollment":223,"conditions":224,"interventions":226},"NCT04682574","Role of Mega Dose of Vitamin C in Critical COVID-19 Patients",[42],"2022-02-28","2022-03-10","2020-11-02",278,[225],"Corona Virus Infection",[202],{"intervention":228,"totalTrials":10,"cells":229},"Instrumental Soft Tissue Mobilization Technique with Conservative Treatment",{"EARLY_PHASE1":230,"PHASE1":232,"PHASE2":234,"PHASE3":236,"PHASE4":238,"NA":240},{"trials":231,"activeCount":12},[],{"trials":233,"activeCount":12},[],{"trials":235,"activeCount":12},[],{"trials":237,"activeCount":12},[],{"trials":239,"activeCount":12},[],{"trials":241,"activeCount":12},[242],{"nctId":243,"briefTitle":244,"status":58,"phases":245,"primaryCompletion":246,"completion":247,"start":248,"enrollment":249,"conditions":250,"interventions":255},"NCT06551922","Effects of IASTM With and Without CT on Pain, ROM, and Functional Disability in Post-Operative Knee Stiffness Patients",[42],"2024-10-14","2024-12-21","2024-01-28",84,[251,252,253,254],"Pain","Pain, Postoperative","Pain, Joint","Knee Pain Chronic",[228,256],"Conservative Treatment",{"intervention":256,"totalTrials":10,"cells":258},{"EARLY_PHASE1":259,"PHASE1":261,"PHASE2":263,"PHASE3":265,"PHASE4":267,"NA":269},{"trials":260,"activeCount":12},[],{"trials":262,"activeCount":12},[],{"trials":264,"activeCount":12},[],{"trials":266,"activeCount":12},[],{"trials":268,"activeCount":12},[],{"trials":270,"activeCount":12},[271],{"nctId":243,"briefTitle":244,"status":58,"phases":272,"primaryCompletion":246,"completion":247,"start":248,"enrollment":249,"conditions":273,"interventions":274},[42],[251,252,253,254],[228,256],{"intervention":276,"totalTrials":10,"cells":277},"1.5g enriched pomegranate muffins",{"EARLY_PHASE1":278,"PHASE1":280,"PHASE2":282,"PHASE3":284,"PHASE4":286,"NA":288},{"trials":279,"activeCount":12},[],{"trials":281,"activeCount":12},[],{"trials":283,"activeCount":12},[],{"trials":285,"activeCount":12},[],{"trials":287,"activeCount":12},[],{"trials":289,"activeCount":12},[290],{"nctId":291,"briefTitle":292,"status":58,"phases":293,"primaryCompletion":294,"completion":295,"start":296,"enrollment":297,"conditions":298,"interventions":301},"NCT07123259","Ulcer Pomegranate Muffins",[42],"2024-10-10","2024-10-12","2024-08-10",82,[299,300],"Gastric","Peptic Ulcer",[276,302],"3g enriched pomegranate muffins",{"intervention":302,"totalTrials":10,"cells":304},{"EARLY_PHASE1":305,"PHASE1":307,"PHASE2":309,"PHASE3":311,"PHASE4":313,"NA":315},{"trials":306,"activeCount":12},[],{"trials":308,"activeCount":12},[],{"trials":310,"activeCount":12},[],{"trials":312,"activeCount":12},[],{"trials":314,"activeCount":12},[],{"trials":316,"activeCount":12},[317],{"nctId":291,"briefTitle":292,"status":58,"phases":318,"primaryCompletion":294,"completion":295,"start":296,"enrollment":297,"conditions":319,"interventions":320},[42],[299,300],[276,302],{"intervention":187,"totalTrials":10,"cells":322},{"EARLY_PHASE1":323,"PHASE1":325,"PHASE2":327,"PHASE3":329,"PHASE4":331,"NA":333},{"trials":324,"activeCount":12},[],{"trials":326,"activeCount":12},[],{"trials":328,"activeCount":12},[],{"trials":330,"activeCount":12},[],{"trials":332,"activeCount":12},[],{"trials":334,"activeCount":12},[335],{"nctId":191,"briefTitle":192,"status":58,"phases":336,"primaryCompletion":194,"completion":195,"start":196,"enrollment":106,"conditions":337,"interventions":338},[42],[16,198,199],[162,187],{"intervention":340,"totalTrials":10,"cells":341},"Control",{"EARLY_PHASE1":342,"PHASE1":344,"PHASE2":346,"PHASE3":348,"PHASE4":350,"NA":352},{"trials":343,"activeCount":12},[],{"trials":345,"activeCount":12},[],{"trials":347,"activeCount":12},[],{"trials":349,"activeCount":12},[],{"trials":351,"activeCount":12},[],{"trials":353,"activeCount":12},[354],{"nctId":355,"briefTitle":356,"status":58,"phases":357,"primaryCompletion":358,"completion":359,"start":360,"enrollment":361,"conditions":362,"interventions":364},"NCT07586969","Modulation of Hyperandrogenic Anovulation Through Fenugreek Seeds",[42],"2024-11-11","2024-12-11","2024-09-11",70,[363],"Poly Cystic Ovary Syndrome",[340],{"intervention":366,"totalTrials":10,"cells":367},"Tocilizumab",{"EARLY_PHASE1":368,"PHASE1":370,"PHASE2":372,"PHASE3":374,"PHASE4":376,"NA":378},{"trials":369,"activeCount":12},[],{"trials":371,"activeCount":12},[],{"trials":373,"activeCount":12},[],{"trials":375,"activeCount":12},[],{"trials":377,"activeCount":12},[],{"trials":379,"activeCount":12},[380],{"nctId":381,"briefTitle":382,"status":58,"phases":383,"primaryCompletion":384,"completion":384,"start":385,"enrollment":386,"conditions":387,"interventions":389},"NCT04690920","Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins",[42],"2020-12-10","2020-07-23",200,[388],"Corona Virus Disease 2019 (COVID-19)",[366],{"intervention":391,"totalTrials":10,"cells":392},"Motor Relearning Program with Electrical Muscle Stimulation",{"EARLY_PHASE1":393,"PHASE1":395,"PHASE2":397,"PHASE3":399,"PHASE4":401,"NA":403},{"trials":394,"activeCount":12},[],{"trials":396,"activeCount":12},[],{"trials":398,"activeCount":12},[],{"trials":400,"activeCount":12},[],{"trials":402,"activeCount":12},[],{"trials":404,"activeCount":12},[405],{"nctId":406,"briefTitle":407,"status":58,"phases":408,"primaryCompletion":409,"completion":410,"start":248,"enrollment":106,"conditions":411,"interventions":414},"NCT06539247","MRP Verses PNF on Pain, Foot Drop, Gait and Functional Mobility in Hemiplegic Patients.",[42],"2024-11-15","2024-12-17",[16,251,412,413,30],"Gait, Drop Foot","Foot Drop",[391,415],"Proprioceptive Neuromuscular Facilitation Technique with Electrical Muscle Stimulation",{"intervention":415,"totalTrials":10,"cells":417},{"EARLY_PHASE1":418,"PHASE1":420,"PHASE2":422,"PHASE3":424,"PHASE4":426,"NA":428},{"trials":419,"activeCount":12},[],{"trials":421,"activeCount":12},[],{"trials":423,"activeCount":12},[],{"trials":425,"activeCount":12},[],{"trials":427,"activeCount":12},[],{"trials":429,"activeCount":12},[430],{"nctId":406,"briefTitle":407,"status":58,"phases":431,"primaryCompletion":409,"completion":410,"start":248,"enrollment":106,"conditions":432,"interventions":433},[42],[16,251,412,413,30],[391,415],{"intervention":435,"totalTrials":10,"cells":436},"Nitroglycerin",{"EARLY_PHASE1":437,"PHASE1":439,"PHASE2":441,"PHASE3":443,"PHASE4":445,"NA":447},{"trials":438,"activeCount":12},[],{"trials":440,"activeCount":12},[],{"trials":442,"activeCount":12},[],{"trials":444,"activeCount":12},[],{"trials":446,"activeCount":12},[],{"trials":448,"activeCount":12},[449],{"nctId":450,"briefTitle":451,"status":58,"phases":452,"primaryCompletion":453,"completion":454,"start":455,"enrollment":223,"conditions":456,"interventions":457},"NCT04686760","Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients",[42],"2021-12-15","2022-03-15","2020-11-15",[225],[435]]